Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries

Jin-Lin Hou(Nanfang Hospital), Seng Gee Lim(National University of Singapore), Jia Shang(Henan Provincial People's Hospital), Jidong Jia, Zhiliang Gao(Sun Yat-sen University), Junqi Niu(First Hospital of Jilin University), Hong Tang(Sichuan University), Hong Ren(First Affiliated Hospital of Xi'an Jiaotong University), Wei Zhao, Hugo Cheinquer(Universidade Federal do Rio Grande do Sul), Yongpeng Chen(Nanfang Hospital), Qing Xie(Ruijin Hospital), Jian Sun(Nanfang Hospital), Guozhong Gong(Central South University), Kwang‐Hyub Han(Yonsei University), Hartwig Klinker(University of Würzburg), Changhyeong Lee(Daegu Catholic University Medical Center), Adrian Streinu‐Cercel(Université Claude Bernard Lyon 1), Jifang Sheng(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Wukui Cao(Tianjin People's Hospital), Jose D. Sollano(University of Santo Tomas), Cheng‐Yuan Peng(China Medical University), Tawesak Tanwandee(Siriraj Hospital), Yanyan Ji(Jingzhou Central Hospital), Tao Han(Tianjin Third Central Hospital), Viacheslav Morozov(University of Florida), Yu‐Ming Wang(Southwest Hospital), Lai Wei(Peking University), Shijun Chen(Jinan Infectious Disease Hospital), Shumei Lin(First Affiliated Hospital of Xi'an Jiaotong University), Mingliang Cheng(Nanyang Medical College), Xiaoping Tang(Guangzhou Eighth People's Hospital), Zhongping Duan(Capital Medical University), Deming Tan(Central South University), Cheng‐Wei Chen(People's Liberation Army 411 Hospital), Hie-Won Hann(Thomas Jefferson University Hospital), Elizabeth Cooney(Bristol-Myers Squibb (United States))
Clinical Gastroenterology and Hepatology
July 12, 2019
Cited by 111


Related Papers